chevron_leftBack
As of 5 June 2026, Heartseed Inc. has a market cap of $262.01M USD, ranking #19410 globally and #1524 in Japan.
It ranks #1750 in the Healthcare sector, and #639 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$262.01MUSD
41.93B JPY
Enterprise Value
$216.15MUSD
34.59B JPY
Revenue (TTM)
$18.91MUSD
3.03B JPY
EBITDA (TTM)
$4.8MUSD
768.26M JPY
Net Income (TTM)
$3.7MUSD
592.5M JPY
EBITDA Margin
25%
Profit Margin
20%
PE Ratio
71.3
PS Ratio
13.9
PB Ratio
5.5
EV/EBITDA
45.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Keiichi Fukuda
open_in_new
Founded
2015
Website
heartseed.jp
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -3.1% | -4.3% | -1.1% | -8% | 1.8% | -19% |
Upcoming Earnings
Earnings Date
Fri, Jun 12
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
219A
Ｈｅａｒｔｓｅｅｄ株式会社
ISIN: JP3765140003
Shares Out.:
Shares Outstanding:
22.874M1
Shares Float:
12.742M2
|
1,777 JPY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Heartseed Inc.
Heartseed Inc. develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure. The company’s lead product is HS-001 for heart failure with reduced ejection fraction indications, including dilated cardiomyopathy, old myocardial infraction, and dilated phase of hypertrophic cardiomyopathy. It also develops products using autologous iPSC and HLA knock-out iPSC. In addition, the company offers differentiation induction, mass culture, purification, and myocardial globule production technology. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TSE: 4519
|
$81.66B
31K%
13.07T JPY
|
28.9
|
|
TSE: 4502
|
$52.21B
20K%
8.36T JPY
|
75.1
|
|
TSE: 4578
|
$36.84B
14K%
5.9T JPY
|
15.7
|
|
TSE: 4568
|
$30.37B
11K%
4.86T JPY
|
16.2
|
|
TSE: 4503
|
$25.82B
10K%
4.13T JPY
|
14.2
|
|
TSE: 4507
|
$16.91B
6K%
2.71T JPY
|
13.9
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
291K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
209K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
138K%
|
97.4
|
|
SIX: RO
|
$324.68B
124K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.25B
110K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$277.35B
106K%
218.9B CHF
|
20.5
|
chevron_leftBack